Health Insights You Can Count On
Sonic Incytes is redefining the standard of care in quantifying liver stiffness and attenuation.
Our mission is to make liver health a new vital sign. Our first product, VelacurTM, aids in the clinical management of patients with liver disease, with measurements you can count on.
Our proprietary technology uses steady state waves, the same used by MRI elastography, to quantify liver stiffness, paving the way for a non-invasive, low-cost and scalable solution for physicians.
We deliver real-time measurements of liver tissue stiffness and attenuation that can be used in conjunction with other clinical indicators to assess chronic liver disease.
Designed with patients in mind, VelacurTM is comfortable, quick and safe for a range of body types.
Sonic Incytes was recognized as a “Company to Watch” at the 25th Annual LSBC Awards Gala, presented by Farris. This...
Velacur™️ ACE Outperforms FibroScan®️ CAP for Liver Fat Quantification We are excited to announce that clinical data from Sonic Incytes’...
Sonic Incytes is pleased to announce they have received Food and Drug Administration (FDA) clearance for new Organ Guide and...
Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund....
